Clinical Trial Update: A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is examining DWP16001 as add-on therapy to Drug A for type 2 diabetes mellitus and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DWP16001
• Drug A

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: RECRUITING